Literature DB >> 33782372

Cardiac Output and Cerebral Blood Flow: A Systematic Review of Cardio-Cerebral Coupling.

Mendel Castle-Kirszbaum1, William Geoffrey Parkin2,3, Tony Goldschlager1,3, Philip M Lewis3,4.   

Abstract

Control of cerebral blood flow (CBF) is crucial to the management of neurocritically ill patients. Small studies which have examined the role of cardiac output (CO) as a determinant of CBF have inconsistently demonstrated evidence of cardio-cerebral coupling. Putative physiological mechanisms underpinning such coupling include changes in arterial blood pressure pulsatility, which would produce vasodilation through increased oscillatory wall-shear-stress and baroreceptor mediated reflex sympatholysis, and changes in venous backpressure which may improve cerebral perfusion pressure. We sought to summarize and contextualize the literature on the relationship between CO and CBF and discuss the implications of cardio-cerebral coupling for neurocritical care. A systematic review of the literature yielded 41 studies; all were of low-quality and at high-risk of bias. Results were heterogenous, with evidence for both corroboration and confutation of a relationship between CO and CBF in both normal and abnormal cerebrovascular states. Common limitations of studies were lack of instantaneous CBF measures with reliance on transcranial Doppler-derived blood flow velocity as a surrogate, inability to control for fluctuations in established determinants of CBF (eg, PaCO 2 ), and direct effects on CBF by the interventions used to alter CO. Currently, the literature is insufficiently robust to confirm an independent relationship between CO and CBF. Hypothetically, the presence of cardio-cerebral coupling would have important implications for clinical practice. Manipulation of CBF could occur without the risks associated with extremes of arterial pressure, potentially improving therapy for those with cerebral ischemia of various etiologies. However, current literature is insufficiently robust to confirm an independent relationship between CO and CBF, and further studies with improved methodology are required before therapeutic interventions can be based on cardio-cerebral coupling.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33782372     DOI: 10.1097/ANA.0000000000000768

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.969


  5 in total

Review 1.  Management of moderate to severe traumatic brain injury: an update for the intensivist.

Authors:  Geert Meyfroidt; Pierre Bouzat; Michael P Casaer; Randall Chesnut; Sophie Rym Hamada; Raimund Helbok; Peter Hutchinson; Andrew I R Maas; Geoffrey Manley; David K Menon; Virginia F J Newcombe; Mauro Oddo; Chiara Robba; Lori Shutter; Martin Smith; Ewout W Steyerberg; Nino Stocchetti; Fabio Silvio Taccone; Lindsay Wilson; Elisa R Zanier; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2022-05-20       Impact factor: 41.787

2.  Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients.

Authors:  C Linda M C van Campen; Peter C Rowe; Frans C Visser
Journal:  Clin Neurophysiol Pract       Date:  2021-09-23

3.  Region-Dependent Increase of Cerebral Blood Flow During Electrically Induced Contraction of the Hindlimbs in Rats.

Authors:  Remi Chaney; Philippe Garnier; Aurore Quirié; Alain Martin; Anne Prigent-Tessier; Christine Marie
Journal:  Front Physiol       Date:  2022-03-23       Impact factor: 4.755

4.  Effect of inotropic agents on oxygenation and cerebral perfusion in acute brain injury.

Authors:  Giacomo Coppalini; Elie Duvigneaud; Alberto Diosdado; Ernesto Migliorino; Sophie Schuind; Jacques Creteur; Fabio Silvio Taccone; Elisa Gouvêa Bogossian
Journal:  Front Neurol       Date:  2022-07-19       Impact factor: 4.086

5.  Compression Stockings Improve Cardiac Output and Cerebral Blood Flow during Tilt Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Patients: A Randomized Crossover Trial.

Authors:  C Linda M C van Campen; Peter C Rowe; Frans C Visser
Journal:  Medicina (Kaunas)       Date:  2021-12-29       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.